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Background. We aimed to describe the incidence of intra-abdominal hypertension (IAH) and gastrointestinal (GI) symptoms and
related outcome in mechanically ventilated (MV) patients. Methods. Intra-abdominal pressure (IAP) and gastric residual volumes
weremeasured atleasttwicedaily. IAHwasdeﬁned asamean dailyvalueofIAP ≥ 12mmHg.Results.398patientsweremonitored
for all together 2987 days. GI symptom(s) occurred in 80.2% patients. 152 (38.2%) patients developed IAH. Majority (93.4%) of
patients with IAH had GI symptoms. The more severe IAH was associated with the higher number of concomitant GI symptoms
(P<. 001). 142 (35.7%) patients developed both IAH and at least one GI symptom at any time in ICU, and in 77 patients they
occurred simultaneously on the same day. This subgroup had the highest ICU mortality (21.8%). In contrast, the small group
of patients presenting only IAH, but not GI symptoms (10 patients), had no lethal outcome. Three patients (4.4%) died without
showing either IAH or GI symptoms. Conclusions. GI symptoms and IAH often, but not always, occur together. The patients
having IAH solely without developing GI symptoms have rather good outcome.
1.Introduction
Intra-abdominal hypertension (IAH) and gastrointestinal
(GI) symptoms occur frequently in ICU patients [1–3], and
both have adverse impact on outcome [1, 3]. However,
their correlations have not been extensively studied. IAP
measurement is becoming more and more routine in ICU
patients, but its role in progress of critical illness is still not
enough clariﬁed. The detrimental consequences of IAH as
well as high mortality of abdominal compartment syndrome
have been well described in recent years [4, 5]. However,
the reasons for the development of IAH as well as the
associations with GI function are so far largely speculative.
IAH is commonly looked at as a separate syndrome, not
directly connected to the function of gastrointestinal system.
In our previous study, we combined enteral feeding intoler-
ance (FI) together with the development of IAH into a GI
failure score, which showed good performance in predicting
ICU mortality [6]. Still, the exact associations between the
occurrence of GI symptoms (vomiting, absence of bowel
sounds, diarrhoea, etc.) and IAH have not been clariﬁed. We
haveobservedthatmostofthepatientswithIAHalsopresent
GI symptoms [6], but in which order and importance these
entities appear is not identiﬁed in previous studies. Whether
intra-abdominal pressure (IAP) might be useful as a single
surrogate marker for GI dysfunction is not clear. It seems
logical to assume that GI dysfunction/failure may be as well
a reason as a result of IAH. From another perspective, IAH
might be considered as a reason for GI symptoms, but also as
a symptom of GI dysfunction.
Intolerance to enteral feeding is not uniformly deﬁned,
often including some again not well-deﬁned GI symptoms
(vomiting, high gastric residual volume, and abdominal
distension) [7]. However, despite the problems in deﬁnition
and reproducibility, the feeding intolerance (FI) has been
suggested as a possible parameter for GI dysfunction/failure
[8]. FI is frequent in intensive care, and its prevalence is
especially high in patients with IAH [6].2 Critical Care Research and Practice
Table 1:Characteristicsofthepatients.Thevaluesforadmissiondayarepresentedasmean(SD)ifnotstatedotherwise.Diﬀerencesbetween
the groups (P value) were found using one-way ANOVA for continuous variables and Kruskal-Wallis test for categorical variables.
Total no IAH or GI
symptoms
IAH or GI
symptoms
both IAH and GI
symptoms P value
Number of patients (%) 398 (100.0) 68 (17.1) 188 (47.2) 142 (35.7)
Male gender, number of patients (%) 256 (64.3) 43 (63.2) 116 (61.7) 97 (68.3) .456
Surgical proﬁle, number of patients (%) 255 (64.1) 28 (41.2) 123 (65.4) 104 (73.2) .001
Vasopressor/inotrope, number of patients (%) 370 (93.0) 58 (85.3) 176 (93.6) 136 (95.8) .019
Age, years 57.3 (18.2) 54.0 (20.0) 57.2 (18.5) 59.0 (16.6) .176
APACHE II, points 15.7 (7.5) 13.3 (7.1) 15.7 (7.6) 16.9 (7.2) .005
SOFA, points 8.3 (3.7) 6.9 (3.2) 8.1 (3.7) 9.1 (3.6) <.001
Body mass index, kg/m2 27.6 (6.2) 26.7 (5.4) 26.8 (5.4) 29.0 (6.6) .013
Fluid balance, L/24h 2.7 (2.9) 2.2 (2.3) 2.5 (2.7) 3.1 (3.3) .056
Urine output, L/24h 1.3 (1.2) 1.4 (0.8) 1.4 (1.3) 1.2 (1.1) .235
Peak inspiratory pressure, cmH2O 26.9 (5.8) 24.8 (5.6) 25.8 (5.3) 29.4 (5.8) <.001
Positive end-expiratory pressure, cmH2O 11.0 (3.8) 9.5 (3.6) 10.3 (3.4) 12.8 (3.7) <.001
Lactate, mmol/L 3.5 (4.4) 2.6 (2.6) 3.5 (4.4) 4.0 (4.9) .096
Table 2: Prevalence of GI symptoms and IAH during the ICU
period and respective outcome of the patients. Diﬀerences between
the groups (P value) were found using one-way ANOVA for
continuous, and Kruskal-Wallis test for categorical variables.
Number of
pt (%)
ICU days
(SD)
Mortality,
pt (%)
Total 398
(100.0) 7.6 (9.1) 52 (13.1)
No GI
symptom, no
IAH
68 (17.1) 2.4 (1.6) 3 (4.4)
GI
symptom(s)
present, no
IAH
178 (44.7) 5.4 (4.9) 18 (10.1)
IAH present,
no GI
symptom(s)
10 (2.5) 4.1 (1.9) 0 (0.0)
Both IAH
and GI
symptoms
present
142 (35.7) 12.9 (12.3) 31 (21.8)
P value <.001 <.001
The aim of our study was to describe the incidence of
IAH and GI symptoms and related outcome in mechanically
ventilated (MV) patients.
2.MaterialsandMethods
Consecutive patients admitted to General ICU of Tartu
University Hospital from October 2006 to June 2009 and
requiring mechanical ventilation for at least 24 hours were
included.
We performed a retrospective analysis of prospectively
collected data, based on electronic database. Respective
Table 3: The occurrence of GI symptoms and IAH according to
their appearance order in patients presenting both of them during
their ICU stay.
Number of
pt (%)
Mortality,
pt (%)
ICU days
(SD)
GI symptom(s)
occurred ﬁrst,
IAH at least one
day later
49 (34.5) 9 (18.4) 12.5 (10.8)
IAH occurred
ﬁrst, GI
symptom(s) at
least one day
later
16 (11.3) 2 (12.5) 14.8 (9.9)
IAH and GI
symptom(s)
occurred
simultaneously
on the same day
77 (54.2) 20 (26.0) 12.8 (13.6)
Diﬀerences in mortality and ICU stay between the groups were not
signiﬁcant (one-way ANOVA and Kruskal-Wallis, resp.).
database was developed for epidemiological studies on
gastrointestinal function and includes daily data of all
the patients admitted to the General ICU of the Tartu
University Hospital since 2004. During the study period, the
measurements of IAP were applied in all MV patients. The
Ethics Committee of the University of Tartu approved the
conduction of the study.
Characteristics of study patients are presented in Table 1.
847 patients were treated for 6673 days in participating unit
during the study period. 398 of them were mechanically
ventilated for at least 24 hours after admission and had
the possibility for IAP measurements. These patients were
included in the study and monitored for 2987 days of
mechanical ventilation in total.Critical Care Research and Practice 3
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Figure 1: Number of GI symptoms that occurred in comparison of
days when IAH was present versus when IAP was normal.
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Figure 2: Development of GI symptoms in groups according to the
level of IAP.
Data for each ICU day with mechanical ventilation were
collected for each patient. IAP was measured intermittently
at least every 6 hours in patients with an IAP ≥ 12mmHg or
at least every 12 hours in patients with an IAP < 12mmHg.
IAP was measured via bladder catheter, at end-expiration
in supine position, using the revised closed system repeated
measurement technique [9]. An instillation volume of 25mL
was used [10]. Mid-axillary line was taken as a zero level
Table 4:ThenumberofdayswithdiﬀerentGIsymptomsaccording
to the presence or absence of IAH at the day of assessment. Data
are presented as number of days (%). Chi-square test was used to
compare the groups.
IAPmean <
12mmHg
IAPmean ≥
12mmHg P value
Absent/abnormal
bowel sounds 672 (29.2) 346 (50.7) <.001
Vomiting 651 (28.3) 331 (48.5) <.001
Gastric residuals
>500mL/day 261 (11.3) 151 (22.1) <.001
Ileus/bowel
distension 117 (5.1) 77 (11.3) <.001
Constipation 147 (6.4) 43 (6.3) .510
Diarrhoea 105 (4.6) 45 (6.6) .023
GI bleeding 42 (1.8) 27 (4.0) .002
Feeding intolerance 377 (16.4) 169 (24.7) <.001
for IAP readings. Mean and maximum values of IAP were
documentedforeachday.Maximumofthemeandailyvalues
of each patient was used to stratify the patient as IAH or no-
IAHpatient.Accordingly,thepatientwasstratiﬁedasanIAH
patientwhenthemeanIAPonatleastonedaywas12mmHg
or higher.
The presence or absence of gastrointestinal symptoms
was documented daily. Gastric residual volumes were mea-
sured at least twice daily by opening of nasogastric tube and
allowing passive outﬂow of gastric content into collection
bagforatleast30minutespermeasurement.Metoclopramid
was commonly used in case of high gastric residuals.
APACHE II [11] was documented for the ﬁrst 24hrs and
SOFA [12] score daily.
2.1. Deﬁnitions.
IAH was deﬁned as a mean daily value of IAP ≥
12mmHg.
Abdominal compartment syndrome (ACS) was deﬁned as
a sustained IAP > 20mmHg with an onset of a new organ
failure [10]. The onset of an organ failure was conﬁrmed by
a SOFA subscore rise to 3 points or above.
Feeding intolerance was deﬁned as forced withdrawal/
reduction of feeding due to vomiting, bowel distension,
diarrhoea, or high nasogastric residuals.
For gastrointestinal symptoms we used the following
institutional deﬁnitions.
Vomiting was deﬁned as regurgitation of gastric contents
in any volume.
Gastrointestinal bleeding was deﬁned as macroscopic
presence of blood in gastric contents or stool.
Absent/abnormal bowel sounds were deﬁned as absent,
pathologically high, or infrequent peristaltics according to
the doctor’s subjective evaluation.
Ileus/bowel distension was documented according to the
radiological diagnosis. Radiological diagnosis was made4 Critical Care Research and Practice
according to the subjective decision of the radiologist, no
clear-cut values for bowel diameter were used.
Diarrhoeawasdeﬁnedasunformedstooloccurringmore
than 3 times/24 hours.
High nasogastric aspirate was deﬁned as gastric residuals
more than 500mL/24hrs.
Constipation w a sd e ﬁ n e da sa b s e n c eo fb o w e lp a s s a g ef o r
5o rm o r ed a y s .
2.2. Group Assignments. (a) Patients according to the devel-
opment of GI symptoms and IAH were divided into the
following groups
(1) no GI symptoms or IAH during the ICU stay,
(2) GI symptom(s) occurred, IAH did not,
(3) IAH occurred, GI symptom(s) did not,
(4) both GI symptom(s) and IAH occurred during the
ICU stay (any time, not necessarily on the same day),
(4.1) GI symptom(s) occurred ﬁrst, IAH at least one
day later,
(4.2) IAH occurred ﬁrst, GI symptom(s) at least one
day later,
(4.3) GI symptom(s) and IAH occurred simultane-
ously on the same day.
(b)ICUdaysaccordingtothepresenceorabsenceofIAH
were divided into
(1) IAPmean < 12mmHg,
(2) IAPmean ≥ 12mmHg.
2.3. Statistics. Statistical Package for the Social Sciences
(Versions 15.0 and 17.0 SPSS Inc., Chicago, Ill, USA)
software was used for statistical analysis.
Continuous variables are expressed as mean (SD) and
categorical data as number of patients (% of patients). Chi-
square test was used for comparisons of two groups (IAH
versus no-IAH). Analysis of variance (one-way ANOVA) for
continuous variables and Kruskal-Wallis test for categorical
variables were used to test the diﬀerences between multiple
groups.
3. Results andDiscussion
Characteristics of the study group are presented in Table 1.
The case-mix does not include cardiac surgical and neu-
rosurgical patients. 105 (26.5%) patients had gastroenteral
pathology on admission, 89 (22.4%) patients were admitted
duetoprimarycardiacorpulmonarydisease,and56patients
(14.1%)werepolytraumapatients.Admissiondiagnosesalso
included intoxications, nephrological, gynaecological, and
orthopaedic pathologies. 144 (36.2%) patients had sepsis on
admission.
At least one GI symptom occurred in 320 (80.4%) study
patients. 152 (38.2%) patients suﬀered from IAH for at least
one day during their ICU stay. This is somewhat higher
incidence than reported previously [1, 3, 6, 13]. Diﬀerent
inclusion criteria are likely the reason for this discrepancy,
as current study included only the patients on mechanical
ventilation for at least 24 hours. Mechanical ventilation itself
is a known risk factor for IAH [10]. To avoid diﬀerent patho-
physiological conditions in ventilated and spontaneously
breathing patients as a confounder, we decided to include
only ventilated patients for IAP measurements.
T h ep r e v a l e n c eo fG Is y m p t o m sa n dI A Ha sw e l la st h e
ICU mortality and length of stay are presented in Table 2.
The study group of 398 patients had mean APACHE II
score of 15.7 (7.5) points and ICU mortality of 12.8% (54
patients). ACS occurred in six (1.5%) patients; four of them
died. The mortality rates and ICU stay diﬀered signiﬁcantly
between the groups. The small group of patients presenting
only IAH, but not GI symptoms, had no lethal outcome.
The prevalence of GI symptoms and IAH according to
their appearance order is presented in Table 3. 142 (35.7%)
of our patients had both IAH and at least one GI symptom at
any time in ICU, and in 77 (19.3%) of them GI symptom(s)
and IAH occurred simultaneously. The ICU mortality rate
and length of stay were not dependent on whether GI
symptoms developed before, after, or simultaneously with
IAH.
IAH was observed in 683 (22.9%) study days, while at
least one GI symptom occurred on 1680 (56.2%) study days.
Enteral feeding was applied in 2176 (72.8%) study days. In
518 days, the enteral feeding was withdrawn/reduced due to
GI problems, thus FI occurred in 23.8% of feeding days. The
numberofdayswithdiﬀerentGIsymptomsandFIaccording
to the presence or absence of IAH is presented in Table 4.
TheprevalenceofGIsymptomsinIAHdayswashigherwhen
compared to the days with normal IAP, P<. 001 between
the groups (Figure 1). 28.3% of IAH-days were free from GI
symptoms. The number of GI symptoms was correlated with
the severity of IAH, P<. 001 between the groups (Figure 2).
These results conﬁrm that not all the patients with
gastrointestinal symptoms develop IAH. Moreover, even if
most of the patients with IAH also show GI symptom(s),
there exists a small group of patients, who suﬀer from IAH,
but do not develop GI symptoms, and in whom the outcome
seems to be better. In our study, all these patients (n = 10)
survived. Based on this, we assume that in some cases IAH
may have a modest role in worsening of the progress of
critical illness.
The main limitations of our study are the subjectivity of
deﬁnitions for GI symptoms and single-centre design. The
absence of clear deﬁnitions of GI symptoms is not surprising
in light of wide range of physiological variability and limited
availability of measurement tools of GI function. This clearly
complicates the research on GI dysfunction/failure. Even
though the clinical importance of auscultation of bowel
sounds [14] as well as the need for measuring the gastric
residuals [15] has been questioned recently, we believe that
the appearance of GI symptoms and GI dysfunction/failure
reﬂect the more severe course of critical illness. The patients
with IAH tend to have higher severity scores, but it is
not the case in patients with GI symptoms. However, the
occurrence of both IAH and GI symptoms is associatedCritical Care Research and Practice 5
w i t ha d v e r s eo u t c o m e .I no u re a r l i e rs t u d y ,w eo b s e r v e d
similar pattern, showing that simultaneous occurrence of
IAH and FI signiﬁcantly impairs the survival [6]. Diagnosis
of FI is usually based on complex clinical evaluation, and
there is no single clear-cut symptom or value [7, 8]. It is
commonly deﬁned through the occurrence of GI symptoms,
which clearly may confuse the diagnostic decisions. For
example, ﬁrst, some GI symptoms are diagnosed subjectively
and thereafter another subjective decision about FI is taken.
Moreover, the impact of FI on the progress of critical
illness might be diﬀerent depending on the deﬁnition and
the symptom(s) leading to this diagnosis. Importantly, an
attempttofeedisakindofpreconditioningfactortodetectFI
atall.Therefore,inacurrentstudy,weassessedGIsymptoms
and FI in separate.
Some of the GI symptoms are most likely the result,
while some of them may be the source of IAH. The exact
correlations are diﬃcult to determine, and with intermittent
measurementofIAPinourstudywecannotclearthisaspect.
We may only speculate on this topic, considering logical
patterns of pathophysiology. However, with this theoretical
approach most of the symptoms may be looked at as a cause
as well as a result of IAH.
Ourresultsmightbeinterpretedinawaythatmostsevere
and long-staying patients develop GI symptoms and IAH.
But then again, all organ failures might be looked at in a
similar way. The main diﬃculty in assessing the abdomi-
nal/gastrointestinal compartment is the lack of terminology
and deﬁnitions of diﬀerent symptoms. IAP as the only easily
measurable variable is probably not enough to describe the
processofcritical illnessregarding GIdysfunction. Therefore
reﬁnement of deﬁnitions of GI symptoms and feeding
intoleranceisofutmostimportance.Whichvariablesprovide
the best reﬂection of GI function needs to be clariﬁed as well.
4. Conclusions
In the present study, we demonstrate that GI symptoms
and IAH often, but not always, occur together. The patients
having IAH solely without developing GI symptoms have
rather good outcome.
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